Primary Aldosteronism and Cerebrovascular Diseases

Zheng Wei Chen; Chi Sheng Hung; Vin Cent Wu; Yen Hung Lin; TAIPAI study group

doi:10.3803/EnM.2018.33.4.429

Primary Aldosteronism and Cerebrovascular Diseases

Endocrinol Metab (Seoul). 2018 Dec;33(4):429-434. doi: 10.3803/EnM.2018.33.4.429.

Authors

Zheng Wei Chen^{1

2}, Chi Sheng Hung¹, Vin Cent Wu¹, Yen Hung Lin³; TAIPAI study group

Affiliations

¹ Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
² Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan.
³ Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. austinr34@gmail.com.

Abstract

As diagnostic techniques have advanced, primary aldosteronism (PA) has emerged as the most common cause of secondary hypertension. The excess of aldosterone caused by PA resulted in not only cardiovascular complications, including coronary artery disease, myocardial infarction, arrhythmia, and heart failure, but also cerebrovascular complications, such as stroke and transient ischemic attack. Moreover, PA is associated more closely with these conditions than is essential hypertension. In this review, we present up-to-date findings on the association between PA and cerebrovascular diseases.

Keywords: Cerebrovascular disorders; Primary aldosteronism; Stroke.

Publication types

Review